Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care

Stock Information for Lucira Health Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lucira Health Inc.

Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing
Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
SESAME PARTNERS WITH LUCIRA HEALTH AS OFFICIAL TELEHEALTH PROVIDER OF LAB-QUALITY TEST-TO-TREAT PROGRAM
Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada
Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test
Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.